Further processing options
A double-blind,multicentre, randomised, placebo-controlled study to assess the efficacy, safety and tolerability of prophylactic liposomal Amphotericin B (AmBisome (R)) for the pre...
Saved in:
Published in: | Blood 124(2014,21) Artikel-Nr. 5946, 1 S. |
---|---|
Authors and Corporations: | , |
Title: | A double-blind,multicentre, randomised, placebo-controlled study to assess the efficacy, safety and tolerability of prophylactic liposomal Amphotericin B (AmBisome (R)) for the prevention of invasive fungal infections in subjects receiving remission-induction chemotherapy for acute lymphoblastic leukaemia (AmBiGuard trial)/ Oliver Cornely, Thibaut Leguay, Johan Maertens, Carlo Castagnola, Achilles Anagnostopoulos, Bernadino Allione, Claus Peter Heussel, J. Peter Donnelly, Samir G. Agrawal, Will Garner, Catherine Simcock, Michael J. Hawkins, Nicola Goekbuget |
Type of Resource: | E-Book Component Part |
Language: | English |
published: |
2014
|
Series: |
: Blood, 124(2014,21) Artikel-Nr. 5946, 1 S.
, volume:124 |
Source: | Verbunddaten SWB Lizenzfreie Online-Ressourcen |
Loading...